If you or someone you know is looking for a potential new treatment option for #UlcerativeColitis (UC), take a moment to learn about the ROSETTA Study, a clinical trial of an investigational medicine. This study is currently enrolling. Learn more: https://bit.ly/3XJ7trL #ClinicalTrialEnrollment #ClinicalTrials
AnaptysBio
Biotechnology Research
San Diego, California 9,328 followers
Transforming patient health by delivering innovative immunology therapeutics.
About us
AnaptysBio ($ANAB) is a clinical-stage biotechnology company focused on transforming patient health by discovering and developing innovative immunology therapeutics. Our broad portfolio of immune cell modulators includes two checkpoint agonists in clinical-stage development. We are dedicated to making a difference in the lives of people living with autoimmune and inflammatory diseases.
- Website
-
https://www.anaptysbio.com
External link for AnaptysBio
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- San Diego, California
- Type
- Public Company
- Founded
- 2005
- Specialties
- Antibodies, Cancer immunotherapy, Inflammation, and Immunology
Locations
-
Primary
10770 Wateridge Circle
Suite 210
San Diego, California 92121, US
Employees at AnaptysBio
Updates
-
Today, we’re shining the spotlight on William T., Senior Scientist 1. Thank you, William, for sharing your positive energy and commitment to great science with us! #WeAreAnaptysBio #CompanyCulture
-
Nothing beats a day on the water with this team! Earlier this week, we celebrated #EmployeeAppreciationDay with our annual all-employee cruise around the beautiful San Diego Bay. The time spent together was priceless. #WeAreAnaptysBio #TeamMemberAppreciation
-
-
🎉 Join us in welcoming Sapna Kabaria, M.D., Nicole Rodrigues, Stefanie Unger, and Giles Hulley to Team Anaptys! Sapna, Nicole, Stefanie, and Giles, we’re so glad to have each of you on board and look forward to achieving great things together. #WeAreAnaptysBio #NewHires
-
In honor of #EmployeeWellnessMonth, we’re spotlighting the connection between work and overall well-being. Take a moment to learn how members of Team Anaptys prioritize their health during the work week. #WeAreAnaptysBio #EmployeeWellness #SelfCare
-
We’re excited to be in San Francisco for the 2024 Federation of Clinical Immunology Societies (FOCIS) meeting. Don’t miss your chance to learn more about our investigational PD-1 agonist and how depletion and agonism of activated T cells presents a potential promising new approach to treating ulcerative colitis during a presentation from Dr. Stephen Parmley, VP, Molecular Biology and Protein Sciences. Read the full poster here: https://lnkd.in/gAQbkvTz #FOCiS2024
-
-
Are you or someone you know looking for relief from #RheumatoidArthritis? Take a moment to learn about RENOIR, a Phase 2b #ClinicalTrial evaluating an investigational treatment for individuals living with RA. This study is currently enrolling. Learn more: https://lnkd.in/gyUmdWAK #ClinicalResearch #NowEnrolling #Rheumatology
-
-
Happy #PrideMonth! At Anaptys, we are committed to fostering a #CompanyCulture that champions diversity and encourages everyone to come to work as their authentic self. #WeAreAnaptysBio
-
-
Over the weekend, members of the Anaptys team participated in the annual Crohn's & Colitis Foundation Take Steps Walk in San Diego. Together, we can make a meaningful impact to accelerate research and improve the quality of life for those living with #UlcerativeColitis and other forms of #InflammatoryBowelDisease. #WeAreAnaptysBio #CompanyCulture #GivingBack
-
-
Join us in extending a warm welcome to John Kwon and Marie-Laure Rives! Their unique perspectives will undoubtedly enrich our #CompanyCulture and ongoing work to transform patient health through innovative immunology therapeutics. #WeAreAnaptysBio #NewHires